Fig. 5. In vitro stability of Centi-C10 antibody in standard buffer formulation compared to PNP hydrogel-encapsulated Centi-C10. (a) In vitro aging assays were conducted by subjecting samples in glass vials to heat and constant agitation. Aliquots were removed at weekly timepoints for analysis of functional stability by ELISA. (b) Post-aging fraction of Centi-C10 binding to SARS-CoV-2 spike RBD antigen by ELISA, normalized by a fridge-stored control (mean ± SD, assayed in triplicate).
